Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Neuland Laboratories Limited (Unit II)
483
•Neuland Laboratories Limited (Unit II)•May 2, 2025

FDA 483 - Neuland Laboratories Limited (Unit II) - May 02, 2025

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Neuland Laboratories Limited (Unit II) in IDA Pashamylaram Village, India, revealed significant deficiencies in facility design and construction. The firm failed to adequately prevent potential cross-contamination of active pharmaceutical ingredients (APIs) due to inadequate controls, shared corridors, and insufficient cleaning validation. This indicates a serious concern regarding the integrity and safety of their manufactured APIs.

Company
Neuland Laboratories Limited (Unit II)
Inspection Date
May 2, 2025
Product Type
Drugs
Office
Office of Biological Products Operations - Division I
People
  • Mabany Lizardi
  • Rowena S. Nguyen
Open in Dashboard

ID · 2af59f72-4493-4231-8649-9a46b8a0f3ae

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.